raloxifene was studied in a clinical trial in the multiple outcomes for raloxifene evaluation study over the course of three years . this study wanted to investigate the effectiveness of raloxifene in minimizing bone loss and maintain bone mineral density. they concluded that there was a reduction in 30% in vertebral fractures on postmenopausal women with osteoporosis on raloxifene.